Vγ2Vδ2 T-cell co-stimulation increases natural killer cell killing of monocyte-derived dendritic cells

Immunology

Volumn 144, Issue 3, 2015, Pages 422-430

  Cairo, Cristiana ^a   Surendran, Naveen ^a   Harris, Kristina M ^a   Mazan Mamczarz, Krystyna ^b   Sakoda, Yukimi ^a   Diaz Mendez, Felisa ^a   Tamada, Koji ^a   Gartenhaus, Ronald B ^b   Mann, Dean L ^a   Pauza, C David ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

co stimulation; dendritic cell; inducible T cell co stimulator; natural killer cell; T cell

Indexed keywords

EID: 85138145773     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/IMM.12386     Document Type: Article

References (52)

1. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995; 375:155–8.
2. Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H. Microbial isopren-oid biosynthesis and human γδ T cell activation. FEBS Lett 2003; 544:4–10.
3. Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, Bloom BR, Golan DE, Brenner MB. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995; 3:495–507.
4. Caccamo N, Todaro M, Sireci G, Meraviglia S, Stassi G, Dieli F. Mechanisms underlying lineage commitment and plasticity of human γδ T cells. Cell Mol Immunol 2013; 10:30–4.
5. Bonneville M, Scotet E. Human Vγ9Vδ2 T cells: promising new leads for immunother-apy of infections and tumors. Curr Opin Immunol 2006; 18:539–46.
6. Braza MS, Klein B, Fiol G, Rossi JF. γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 mono-clonal antibody. Haematologica 2011; 96:400–7.
7. + breast cancer. J Immunol 2011; 187:1031–8.
8. Gertner-Dardenne J, Bonnafous C, Bezombes C et al. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic anti-bodies. Blood 2009; 113:4875–84.
9. Davodeau F, Peyrat MA, Hallet MM, Houde I, Vie H, Bonneville M. Peripheral selec-tion of antigen receptor junctional features in a major human γδ subset. Eur J Immunol 1993; 23:804–8.
10. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vγ2-Jγ1.2/Vδ2 T-cell receptors. Immunology 2001; 104:19–27.
11. Davodeau F, Peyrat MA, Hallet MM, Gaschet J, Houde I, Vivien R, Vie H, Bonneville M. Close correlation between Daudi and mycobacterial antigen recognition by human γδ T cells and expression of V9JPC1 γ/V2DJC δ-encoded T cell receptors. J Immunol 1993; 151:1214–23.
12. + T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002; 168:1484–9.
13. Holtmeier W, Kabelitz D. γδ T cells link innate and adaptive immune responses. Chem Immunol Allergy 2005; 86:151–83.
14. Martino A, Casetti R, D’Alessandri A, Sacchi A, Poccia F. Complementary function of γδ T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens. J Clin Immunol 2005; 25:230–7.
15. Martino A, Casetti R, Poccia F. Enhancement of BCG-induced Th1 immune response through Vγ9Vδ2 T cell activation with non-peptidic drugs. Vaccine 2007; 25:1023–9.
16. Fiore F, Castella B, Nuschak B et al. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Blood 2007; 110:921–7.
17. Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines. J Immunol 2005; 174:252–60.
18. Caccamo N, Battistini L, Bonneville M et al. CXCR5 identifies a subset of Vγ9Vδ2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J Immunol 2006; 177:5290–5.
19. Caccamo N, Todaro M, La Manna MP, Sireci G, Stassi G, Dieli F. IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. PLoS ONE 2012; 7:e41940.
20. Bansal RR, Mackay CR, Moser B, Eberl M. IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur J Immunol 2012; 42:110–9.
21. + αβ T cell responses. Proc Natl Acad Sci USA 2009; 106:2307–12.
22. Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human γδ T cells. Science 2005; 309:264–8.
23. Angelini DF, Zambello R, Galandrini R et al. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease. J Leukoc Biol 2011; 89:75–84.
24. Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B. Differentiation of human peripheral blood Vdelta1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 2011; 118:992–1001.
25. Halary F, Peyrat MA, Champagne E et al. Control of self-reactive cytotoxic T lympho-cytes expressing γδ T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997; 27:2812–21.
26. Poccia F, Cipriani B, Vendetti S et al. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J Immunol 1997; 159:6009–17.
27. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of Vγ 9Vδ2 T cells by NKG2D. J Immunol 2005; 175:2144–51.
28. Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, Chapoval AI. Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 2010; 116:1726–33.
29. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343–51.
30. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195:327–33.
31. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195:335–41.
32. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005; 106:609–16.
33. Carbone E, Terrazzano G, Ruggiero G, Zanzi D, Ottaiano A, Manzo C, Karre K, Zappacosta S. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999; 29:4022–9.
34. Melki MT, Saidi H, Dufour A, Olivo-Marin JC, Gougeon ML. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk–a pivotal role of HMGB1. PLoS Pathog 2010; 6:e1000862.
35. Alter G, Kavanagh D, Rihn S, Luteijn R, Brooks D, Oldstone M, van Lunzen J, Altfeld M. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the con-text of HIV infection. J Clin Invest 2010; 120:1905–13.
36. Morandi B, Mortara L, Chiossone L, Accolla RS, Mingari MC, Moretta L, Moretta A, Ferlazzo G. Dendritic cell editing by activated natural killer cells results in a more pro-tective cancer-specific immune response. PLoS ONE 2012; 7:e39170.
37. Li H, Chaudry S, Poonia B, Shao Y, Pauza CD. Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol Immunol 2013; 10:42–9.
38. Pauza CD, Riedel DJ, Gilliam BL, Redfield RR. Targeting γδ T cells for immunotherapy of HIV disease. Future Virol 2011; 6:73–84.
39. Harris KM. Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J Leukoc Biol 2011; 90:727–34.
40. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197:163–8.
41. + T cells to differentiate into CTL. Eur J Immunol 2007; 37:1678–90.
42. Garcia VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT, Modlin RL. IL-15 enhances the response of human γδ T cells to nonpeptide [correction of nonpetide] microbial antigens. J Immunol 1998; 160:4322–9.
43. Liu C, Lou Y, Lizee G et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 2008; 118:1165–75.
44. Hanabuchi S, Watanabe N, Wang YH, Ito T, Shaw J, Cao W, Qin FX, Liu YJ. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006; 107:3617–23.
45. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells’ immunological modalities revealed by gene expression profiling. J Immunol 2004; 173:6547–63.
46. Ndhlovu LC, Lopez-Verges S, Barbour JD et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012; 119:3734–43.
47. Gleason MK, Lenvik TR, McCullar V et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon γ production in response to galectin-9. Blood 2012; 119:3064–72.
48. Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K. Pim-1 controls NF-kB signalling by stabilizing RelA/p65. Cell Death Differ 2010; 17:689–98.
49. Tikhonov I, Deetz CO, Paca R, Berg S, Lukyanenko V, Lim JK, Pauza CD. Human Vγ2Vδ2 T cells contain cytoplasmic RANTES. Int Immunol 2006; 18:1243–51.
50. Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 2003; 15:704–8.
51. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regu-lation. Nat Rev Immunol 2007; 7:454–65.
52. Parker CM, Groh V, Band H et al. Evidence for extrathymic changes in the T cell receptor γδ repertoire. J Exp Med 1990; 171:1597–612.